Transcatheter Aortic Valve Implantation with a CoreValveô Bioprosthesis in a 57-Year-Old Man
|
Mehmet Bilge, Hatice Tolunay, Ayse Saatci Yasar, Recai Alemdar, Sina Ali, Ozge Kurmus Ataturk Education and Research Hospital, Cardiology Department, Ankara, Turkey |
|
|
Transcatheter aortic valve implantation (TAVI) is a promising new technology which is typically used to treat elderly patients with severe aortic stenosis who cannot undergo surgical aortic valve replacement due to high risk factors. This procedure may also be a therapeutic option in particular relatively young cases with severe symptomatic aortic stenosis who are unsuitable candidates for surgery. Clinical experience with TAVI in these patients is very limited due to concerns |
regarding long-term valve durability. Herein, the case is reported of a 57-year-old man with severe aortic stenosis who presented with decompensated heart failure and successfully underwent transfemoral CoreValve™ implantation. To the best of the present authors’ knowledge, this is the youngest reported patient to have received a CoreValve bioprosthesis to date. |
| Transcatheter Aortic Valve Implantation with a CoreValve™ Bioprosthesis in a 57-Year-Old Man | |
Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.
Purchase this Article
Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.
Website by CHP Design, London